Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Freek J Bot"'
Autor:
Freek J Bot, Arjen H.G. Cleven, Ronald van Eijk, Tom van Wezel, Paul Geraeds Kemps, Jean-Louis H. Kerkhoffs, Peter van Balen, Hendrik Veelken
Publikováno v:
American Journal of Hematology, 95(11), 1427-1429. WILEY
American Journal of Hematology
American Journal of Hematology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04c8c5551f9606d53b22255365be1fb
http://hdl.handle.net/1887/3184230
http://hdl.handle.net/1887/3184230
Autor:
Suzanne M, Koopmans, Freek J, Bot, Harry C, Schouten, Jannie, Janssen, Arienne Mw, van Marion
Publikováno v:
American journal of blood research. 2(2)
In patients with myeloproliferative neoplasia (MPN) the development of fibrosis and increased vessel density correlate with poor prognosis. The JAK2(V617F) mutation constitutively activates JAK2, which phosphorylates signal transducer activator of tr
Autor:
Hendrik De Raeve, Suzanne M. Koopmans, Konnie M. Hebeda, Arienne M. W. van Marion, King H. Lam, Freek J Bot
Publikováno v:
American Journal of Clinical Pathology, 136, 4, pp. 618-24
American Journal of Clinical Pathology, 136(4), 618-624. Oxford University Press
American journal of clinical pathology
American Journal of Clinical Pathology, 136, 618-24
American Journal of Clinical Pathology, 136(4), 618-624. American Society of Clinical Pathologists
American Journal of Clinical Pathology, 136(4), 618-624. Oxford University Press
American journal of clinical pathology
American Journal of Clinical Pathology, 136, 618-24
American Journal of Clinical Pathology, 136(4), 618-624. American Society of Clinical Pathologists
Contains fulltext : 98307.pdf (Publisher’s version ) (Closed access) Early phases of polycythemia vera, essential thrombocythemia, and primary myelofibrosis (PMF) can be difficult to distinguish by morphologic studies alone because they share many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e737958b0df697ff2c9181c2fea20e77
https://hdl.handle.net/2066/98307
https://hdl.handle.net/2066/98307
Autor:
Catharina H M J, Van Elssen, Peter W H, Frings, Freek J, Bot, Koen K, Van de Vijver, Mariska B, Huls, Bob, Meek, Pierre, Hupperets, Wilfred T V, Germeraad, Gerard M J, Bos
Publikováno v:
Histopathology. 57(4)
Mucin 1 (MUC1) is an important tumour-associated antigen (TAA), both overexpressed and aberrantly glycosylated in adenocarcinomas. The aim of this study was to examine the MUC1-glycosylation status of primary ovarian adenocarcinomas and metastatic le
Publikováno v:
European journal of haematology. 85(1)